Bliss GVS Pharma Ltd
BLISSGVS
Company Profile
Business description
Bliss GVS Pharma Ltd is engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. The Company is among the world leaders in suppositories and pessaries dosage forms, with one of the highest portfolios in this segment. It operates its own WHO-GMP-approved manufacturing facilities at Palghar and generates the majority of its revenue from markets outside India.
Contact
Saki Vihar Road
102, Hyde Park
Andheri (East)
MumbaiMH400072
INDT: +91 2242160000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
1,033
Stocks News & Analysis
stocks
ASX utility share downgraded as electricity prices fall
Falling electricity prices weigh on earnings outlook for utility provider.
stocks
Chart of the Week: AI market leader is now surprisingly cheap
This AI beneficiary may still be one of the market’s most compelling bargains.
stocks
Weekly earnings wrap: Rio Tinto leads the way
A closer look at the key earnings results from the first week of August reporting.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,454.10 | 44.20 | 0.47% |
| CAC 40 | 8,669.30 | 0.00 | 0.00% |
| DAX 40 | 26,126.30 | 76.05 | -0.29% |
| Dow JONES (US) | 54,349.12 | 263.24 | 0.49% |
| FTSE 100 | 10,888.30 | 8.92 | 0.08% |
| HKSE | 25,420.91 | 494.91 | -1.91% |
| NASDAQ | 26,363.44 | 221.55 | -0.83% |
| Nikkei 225 | 65,402.27 | 898.17 | -1.35% |
| NZX 50 Index | 13,961.69 | 35.49 | -0.25% |
| S&P 500 | 7,723.55 | 12.97 | -0.17% |
| S&P/ASX 200 | 9,272.10 | 42.30 | 0.46% |
| SSE Composite Index | 3,878.92 | 0.49 | 0.01% |